Adcendo
Drug DiscoveryWebsite
Developer of antibody-drug conjugates designed to create new medicines for cancer patients with significant unmet needs. The company's conjugates are directed at a target receptor, which is an approac...
Valuation
$209.9M
Market implied
Share Price
N/A
Total Raised
$240.9M
Last Round
Later Stage VC (Series B)
Nov 2024
Latest Funding Round
Later Stage VC (Series B)
Nov 6, 2024
$134.1M
raised
Investors
+17 other investors